IHC-plus(tm) ERG Antibody (aa469-481)

LifeSpan BioSciences

IHC-plus(tm) ERG Antibody (aa469-481)

23

Human ERG. This antibody is expected to recognise both reported isoforms (NP_891548.1; NP_004440.1)

Immunohistochemistry: LS-B9 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B9 was determined to be 10 ug/ml.. IHC, IHC-P (10 µg/ml), Peptide-ELISA (1:16000), WB (0.1 - 0.3 µg/ml) Immunohistochemistry: LS-B9 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B9 was determined to be 10 ug/ml.

Western Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Research Use Only

Polyclonal

0.5 mg/ml

Unconjugated

...

ERG

ETS transcription factor ERG

ERG, ETS transcription factor; erg-3; erythroblast transformation-specific transcription factor ERG variant 10; ets-related; FUS/ERG fusion protein; p55; TMPRSS2/ERG fusion; transcriptional regulator ERG; transcriptional regulator ERG (transforming protein ERG); v-ets avian erythroblastosis virus E26 oncogene homolog; v-ets avian erythroblastosis virus E26 oncogene related; v-ets erythroblastosis virus E26 oncogene homolog; v-ets erythroblastosis virus E26 oncogene like

Goat

Human, Monkey

-20°C

12352203